FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090890003> ?p ?o ?g. }

• W2090890003 endingPage "1432" @default.
• W2090890003 startingPage "1423" @default.
• W2090890003 abstract "L-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplant recipients.BackgroundThe “L-arginine paradox” refers to situations where L-arginine (L-Arg) supplementation stimulates nitric oxide (NO) synthesis, despite saturating intracellular concentrations. This paradox is frequently observed in acute renal failure (ARF). First, the effects of L-Arg on renal function of rats with ARF were studied. Based on the promising results from these initial studies, the second part of our study searched for a form of ARF in humans that could be studied easily under conditions with little variance and yet was linked with endothelial dysfunction. Thus, we investigated the effects of L-Arg supplementation immediately after kidney transplantation in 54 patients.MethodsIn uranyl nitrate-induced ARF in rats the effects of L-Arg and L-NNA (inhibitor of nitric oxide synthase; NOS) on glomerular filtration rate (GFR), renal plasma flow (RPF), blood pressure (BP) and NOx (NO2-+NO3-) excretion were examined. Tissue L-Arg levels, NOS activities, immunodetection of NOS and superoxide dismutase (SOD), activities of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine oxidase, and nitrotyrosine immunoreactive protein (NT-IR) were determined and compared to sham operated animals. Secondly, in a randomized, double-blind study, the effects of L-Arg on GFR and RPF were investigated in 54 kidney transplant recipients, receiving IV L-Arg for three days. GFR and RPF were measured on days 1, 3, 5 and 10 by scintigraphy.ResultsIn experimental ARF, decreased RPF and GFR were associated with reduced tissue L-Arg levels, endothelial NOS-III expression, NO formation and NOx excretion. Reduction in GFR, RPF and NOx excretion were reversed upon administration of exogenous L-Arg. There also was a loss of Cu,Zn-SOD, a key enzyme against oxidative stress, and an elevation of NT-IR, an indicator of nitrosative stress and suggested marker for pathological actions of NO. However, NT-IR was not dependent on de novo NO synthesis and not related to the functional effects of L-Arg administration. In kidney transplant recipients receiving organs with a short cold ischemia time (CIT) and from young donors, that is, those with a higher likelihood of a functional endothelium, early administration of L-Arg improved renal function.ConclusionBoth experimental and clinical data show that L-Arg deficiency and endothelial dysfunction are pathomechanistically relevant in ARF. The data suggest a therapeutic potential for the administration of L-Arg in ARF and kidney transplantation, at least in patients receiving kidneys with shorter CIT and from younger donors. L-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplant recipients. The “L-arginine paradox” refers to situations where L-arginine (L-Arg) supplementation stimulates nitric oxide (NO) synthesis, despite saturating intracellular concentrations. This paradox is frequently observed in acute renal failure (ARF). First, the effects of L-Arg on renal function of rats with ARF were studied. Based on the promising results from these initial studies, the second part of our study searched for a form of ARF in humans that could be studied easily under conditions with little variance and yet was linked with endothelial dysfunction. Thus, we investigated the effects of L-Arg supplementation immediately after kidney transplantation in 54 patients. In uranyl nitrate-induced ARF in rats the effects of L-Arg and L-NNA (inhibitor of nitric oxide synthase; NOS) on glomerular filtration rate (GFR), renal plasma flow (RPF), blood pressure (BP) and NOx (NO2-+NO3-) excretion were examined. Tissue L-Arg levels, NOS activities, immunodetection of NOS and superoxide dismutase (SOD), activities of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine oxidase, and nitrotyrosine immunoreactive protein (NT-IR) were determined and compared to sham operated animals. Secondly, in a randomized, double-blind study, the effects of L-Arg on GFR and RPF were investigated in 54 kidney transplant recipients, receiving IV L-Arg for three days. GFR and RPF were measured on days 1, 3, 5 and 10 by scintigraphy. In experimental ARF, decreased RPF and GFR were associated with reduced tissue L-Arg levels, endothelial NOS-III expression, NO formation and NOx excretion. Reduction in GFR, RPF and NOx excretion were reversed upon administration of exogenous L-Arg. There also was a loss of Cu,Zn-SOD, a key enzyme against oxidative stress, and an elevation of NT-IR, an indicator of nitrosative stress and suggested marker for pathological actions of NO. However, NT-IR was not dependent on de novo NO synthesis and not related to the functional effects of L-Arg administration. In kidney transplant recipients receiving organs with a short cold ischemia time (CIT) and from young donors, that is, those with a higher likelihood of a functional endothelium, early administration of L-Arg improved renal function. Both experimental and clinical data show that L-Arg deficiency and endothelial dysfunction are pathomechanistically relevant in ARF. The data suggest a therapeutic potential for the administration of L-Arg in ARF and kidney transplantation, at least in patients receiving kidneys with shorter CIT and from younger donors." @default.
• W2090890003 created "2016-06-24" @default.
• W2090890003 creator A5023557758 @default.
• W2090890003 creator A5025448577 @default.
• W2090890003 creator A5030982149 @default.
• W2090890003 creator A5033368647 @default.
• W2090890003 creator A5036354220 @default.
• W2090890003 creator A5040063360 @default.
• W2090890003 creator A5053274881 @default.
• W2090890003 creator A5053956088 @default.
• W2090890003 creator A5060388165 @default.
• W2090890003 creator A5071605212 @default.
• W2090890003 creator A5075132107 @default.
• W2090890003 creator A5079825297 @default.
• W2090890003 date "2002-04-01" @default.
• W2090890003 modified "2023-10-15" @default.
• W2090890003 title "L-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation" @default.
• W2090890003 cites W1725300350 @default.
• W2090890003 cites W1764308599 @default.
• W2090890003 cites W1821918060 @default.
• W2090890003 cites W1945701558 @default.
• W2090890003 cites W1964267255 @default.
• W2090890003 cites W1964465727 @default.
• W2090890003 cites W1971061508 @default.
• W2090890003 cites W1983855526 @default.
• W2090890003 cites W1988726352 @default.
• W2090890003 cites W1988951836 @default.
• W2090890003 cites W1997677650 @default.
• W2090890003 cites W2005466083 @default.
• W2090890003 cites W2007013508 @default.
• W2090890003 cites W2007375934 @default.
• W2090890003 cites W2013023382 @default.
• W2090890003 cites W2016470389 @default.
• W2090890003 cites W2019663704 @default.
• W2090890003 cites W2020694286 @default.
• W2090890003 cites W2023643206 @default.
• W2090890003 cites W2025587642 @default.
• W2090890003 cites W2042695353 @default.
• W2090890003 cites W2058385357 @default.
• W2090890003 cites W2063024150 @default.
• W2090890003 cites W2063504655 @default.
• W2090890003 cites W2065432913 @default.
• W2090890003 cites W2081188174 @default.
• W2090890003 cites W2088023459 @default.
• W2090890003 cites W2092947671 @default.
• W2090890003 cites W2100698530 @default.
• W2090890003 cites W2112083906 @default.
• W2090890003 cites W2114443210 @default.
• W2090890003 cites W2118863177 @default.
• W2090890003 cites W2133135624 @default.
• W2090890003 cites W2139179601 @default.
• W2090890003 cites W4232190254 @default.
• W2090890003 cites W4234071946 @default.
• W2090890003 cites W4243457935 @default.
• W2090890003 cites W4293247451 @default.
• W2090890003 cites W1972090467 @default.
• W2090890003 doi "https://doi.org/10.1046/j.1523-1755.2002.00268.x" @default.
• W2090890003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11918749" @default.
• W2090890003 hasPublicationYear "2002" @default.
• W2090890003 type Work @default.
• W2090890003 sameAs 2090890003 @default.
• W2090890003 citedByCount "73" @default.
• W2090890003 countsByYear W20908900032012 @default.
• W2090890003 countsByYear W20908900032013 @default.
• W2090890003 countsByYear W20908900032014 @default.
• W2090890003 countsByYear W20908900032015 @default.
• W2090890003 countsByYear W20908900032016 @default.
• W2090890003 countsByYear W20908900032017 @default.
• W2090890003 countsByYear W20908900032018 @default.
• W2090890003 countsByYear W20908900032019 @default.
• W2090890003 countsByYear W20908900032020 @default.
• W2090890003 countsByYear W20908900032021 @default.
• W2090890003 countsByYear W20908900032023 @default.
• W2090890003 crossrefType "journal-article" @default.
• W2090890003 hasAuthorship W2090890003A5023557758 @default.
• W2090890003 hasAuthorship W2090890003A5025448577 @default.
• W2090890003 hasAuthorship W2090890003A5030982149 @default.
• W2090890003 hasAuthorship W2090890003A5033368647 @default.
• W2090890003 hasAuthorship W2090890003A5036354220 @default.
• W2090890003 hasAuthorship W2090890003A5040063360 @default.
• W2090890003 hasAuthorship W2090890003A5053274881 @default.
• W2090890003 hasAuthorship W2090890003A5053956088 @default.
• W2090890003 hasAuthorship W2090890003A5060388165 @default.
• W2090890003 hasAuthorship W2090890003A5071605212 @default.
• W2090890003 hasAuthorship W2090890003A5075132107 @default.
• W2090890003 hasAuthorship W2090890003A5079825297 @default.
• W2090890003 hasBestOaLocation W20908900031 @default.
• W2090890003 hasConcept C126322002 @default.
• W2090890003 hasConcept C134018914 @default.
• W2090890003 hasConcept C142225936 @default.
• W2090890003 hasConcept C159641895 @default.
• W2090890003 hasConcept C181199279 @default.
• W2090890003 hasConcept C185592680 @default.
• W2090890003 hasConcept C2777622882 @default.
• W2090890003 hasConcept C2777989768 @default.
• W2090890003 hasConcept C2778102346 @default.
• W2090890003 hasConcept C2780091579 @default.
• W2090890003 hasConcept C2911091166 @default.

• next